Peter Reinli - ScandiDos Vice President of Sales
| SDOS Stock | SEK 1.70 0.05 3.03% |
Insider
Peter Reinli is Vice President of Sales of ScandiDos AB since 2019.
| Age | 62 |
| Tenure | 5 years |
| Phone | 46 1 84 72 30 30 |
| Web | https://scandidos.com |
ScandiDos Management Efficiency
The company has return on total asset (ROA) of (0.1117) % which means that it has lost $0.1117 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2832) %, meaning that it generated substantial loss on money invested by shareholders. ScandiDos' management efficiency ratios could be used to measure how well ScandiDos manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Dan Mogren | Clinical Laserthermia Systems | N/A | |
| Michael Colrus | Scibase AB | 61 | |
| LarsErik Eriksson | Clinical Laserthermia Systems | 74 | |
| David Vikstrm | Xbrane Biopharma AB | 46 | |
| Erik Domines | Xbrane Biopharma AB | 59 | |
| Mats Ekelund | Clinical Laserthermia Systems | N/A | |
| Associate Gier | Xbrane Biopharma AB | N/A | |
| Anette Lindqvist | Xbrane Biopharma AB | 57 | |
| Stephan MSc | Clinical Laserthermia Systems | 68 | |
| Nina Ivers | Xbrane Biopharma AB | 53 | |
| Sanna Rydberg | Arcoma AB | 54 | |
| Linn Olsen | Scibase AB | 46 | |
| Rolf Bornschein | Clinical Laserthermia Systems | N/A | |
| Maria Edebrink | Xbrane Biopharma AB | 54 | |
| Samuel Wagner | Xbrane Biopharma AB | N/A | |
| Martin mark | Xbrane Biopharma AB | 43 | |
| Marie MSc | Clinical Laserthermia Systems | 44 | |
| Johan Dahlberg | Arcoma AB | 39 | |
| Karin Peterson | Clinical Laserthermia Systems | N/A | |
| Frida Robbe | Arcoma AB | 38 | |
Management Performance
| Return On Equity | -0.28 | |||
| Return On Asset | -0.11 |
ScandiDos AB Leadership Team
Elected by the shareholders, the ScandiDos' board of directors comprises two types of representatives: ScandiDos inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ScandiDos. The board's role is to monitor ScandiDos' management team and ensure that shareholders' interests are well served. ScandiDos' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ScandiDos' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gorgen Nilsson, Chief Executive Officer | ||
| Henriette Munch, Chief Officer | ||
| Peter Reinli, Vice President of Sales | ||
| Carl Piehl, Chief Officer | ||
| Anders Adolfson, Director of Marketing |
ScandiDos Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ScandiDos a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.28 | |||
| Return On Asset | -0.11 | |||
| Profit Margin | (0.18) % | |||
| Operating Margin | (0.20) % | |||
| Current Valuation | 103.49 M | |||
| Shares Outstanding | 45.61 M | |||
| Shares Owned By Insiders | 58.75 % | |||
| Shares Owned By Institutions | 3.30 % | |||
| Price To Earning | 3.26 X | |||
| Price To Book | 2.69 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for ScandiDos Stock Analysis
When running ScandiDos' price analysis, check to measure ScandiDos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ScandiDos is operating at the current time. Most of ScandiDos' value examination focuses on studying past and present price action to predict the probability of ScandiDos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ScandiDos' price. Additionally, you may evaluate how the addition of ScandiDos to your portfolios can decrease your overall portfolio volatility.